CrossrefInfokarte
Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · 436-442
DOI: 10.3816/clm.2009.n.086 ↗Abstract
Kein Abstract verfügbar.
EUVIMED